TRILIC Turkish stock broke 5 Month down TrendWe just break 5 Month resistance and retest the support which hold ,both long term and short term trend Indicator showing Long signal and target 18% and then 48% and trailing with Red trend line
0.56 TRY
105.72 M TRY
1.91 B TRY
96.86 M
About TURK ILAC SERUM
Sector
CEO
Yunus Emre Battal
Headquarters
Ankara
Website
Founded
2010
ISIN
TRETRLC00022
FIGI
BBG00ZF0BCT5
Türk Ilaç ve Serum Sanayi AS engages in the manufacture of medical drugs. It offers intravenous fluids, vaccines, premixes, Hemodialysis solutions, as well as diagnostic and immunostimulant products. The company was founded by Mehmet Berat Battal in 2010 and is headquartered in Ankara, Turkey.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of TRILC is 16.37 TRY — it has decreased by −2.33% in the past 24 hours. Watch TURK ILAC SERUM stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIST exchange TURK ILAC SERUM stocks are traded under the ticker TRILC.
TRILC stock has fallen by −2.79% compared to the previous week, the month change is a −14.20% fall, over the last year TURK ILAC SERUM has showed a 38.03% increase.
TRILC reached its all-time high on May 21, 2024 with the price of 39.18 TRY, and its all-time low was 5.24 TRY and was reached on Mar 5, 2021. View more price dynamics on TRILC chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
TRILC stock is 3.07% volatile and has beta coefficient of 0.96. Track TURK ILAC SERUM stock price on the chart and check out the list of the most volatile stocks — is TURK ILAC SERUM there?
Today TURK ILAC SERUM has the market capitalization of 2.65 B, it has decreased by −3.42% over the last week.
Yes, you can track TURK ILAC SERUM financials in yearly and quarterly reports right on TradingView.
TRILC net income for the last quarter is 1.29 M TRY, while the quarter before that showed 92.97 M TRY of net income which accounts for −98.61% change. Track more TURK ILAC SERUM financial stats to get the full picture.
No, TRILC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 439.00 employees. See our rating of the largest employees — is TURK ILAC SERUM on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TURK ILAC SERUM EBITDA is 562.48 M TRY, and current EBITDA margin is 15.80%. See more stats in TURK ILAC SERUM financial statements.
Like other stocks, TRILC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TURK ILAC SERUM stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TURK ILAC SERUM technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TURK ILAC SERUM stock shows the strong sell signal. See more of TURK ILAC SERUM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.